NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: C000000271

Registered date:31/10/2005

A phase II study of cisplatin with TS-1 for patients with cancer of primary unknown

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedcancer of primary unknown
Date of first enrollment2005/10/01
Target sample size45
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Chemotherapy

Outcome(s)

Primary OutcomeResponse Rate
Secondary OutcomeSafety Profile

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum99years-old
GenderMale and Female
Include criteria
Exclude criteriaThe exclusion criteria are as follows: 1.female adenocarcinoma with axillary lymph nodes swelling only, or pelvic cavity endolymph nodes only 2.squamous carcinoma with cervical lymph nodes swelling only, or inguen lymph nodes only 3.patients with germ cell tumor or have characteristic of neuroendocrine tumor 4.patients with high level of PSA in serum or tumor (1) severe infection or other severe complications (such as gastrointestinal bleeding, heart disease) (2) symptomatic brain metastasis (3) patients who carried out bone marrow transplantation (4) patients who carried out peripheral blood stem cell transplantation (5) drug allergy (6) pregnancy or lactating (7) male patients who hope for pregnancy (8) uncontrollable diabetes mellitus

Related Information

Contact

public contact
Name Takayasu Kurata
Address 377-2, Ohno-Higashi, Osakasayama, Osaka Japan
Telephone 072-366-0221
E-mail t-kurata@med.kindai.ac.jp
Affiliation Kinki University School of Medicine Department of Medical Oncology
scientific contact
Name Takayasu Kurata
Address 377-2, Ohno-Higashi, Osakasayama, Osaka Japan
Telephone 072-366-0221
E-mail kuratat@hirakata.kmu.ac.jp
Affiliation Kinki University School of Medicine Department of Medical Oncology